"The US Food and Drug Administration has approved a blood test to aid in the diagnosis of Alzheimer's disease - the second such test and the first cleared for use in primary-care settings, such as a doctor's office. The test measures Alzheimer's-related proteins to rule out the disease in people with cognitive decline. Last week, pharma company Roche announced that the test was correctly able to rule out Alzheimer's 97.9% of the time."
"Passing the Turing test - a thought experiment that asks whether a computer's written conversation can pass as a person's - is a piece of cake for the best artificial intelligence (AI) models. First proposed by mathematician Alan Turing 75 years ago, some researchers want to see an upgraded test to use as a benchmark for progress towards artificial general intelligence - models with the resourcefulness to match human cognitive ability."
The US Food and Drug Administration approved a blood test to aid diagnosis of Alzheimer's disease, marking the second such test and the first cleared for primary-care settings. The assay measures Alzheimer's-related proteins and, according to Roche, ruled out Alzheimer's in 97.9% of tested cases, but independent assessment is limited without full trial data. Some researchers argue that the Turing test is an inadequate benchmark for progress toward artificial general intelligence and propose upgraded evaluations, while others advocate focusing on AI safety and specific public-benefit capabilities. Guidelines recommending early peanut feeding correlated with a 43% drop in peanut allergies in under-threes.
Read at Nature
Unable to calculate read time
Collection
[
|
...
]